北美输血诊断市场预测至 2028 年 - COVID-19 影响和按产品（仪器、试剂盒和试剂）、应用（血型和疾病筛查）和最终用户（医院、诊断实验室、血库和血浆）进行的区域分析分馏公司）
No. of Pages: 128 | Report Code: BMIRE00027389 | Category: Life Sciences
No. of Pages: 128 | Report Code: BMIRE00027389 | Category: Life Sciences
北美输血诊断市场预计将从2022年的18.1582亿美元增长到2028年的27.428亿美元。预计2022年至2028年复合年增长率为7.1% .
器官移植手术的增加导致输血需求推动市场增长
器官移植是在心脏、肝脏和肾脏等器官衰竭的情况下进行的外科手术。慢性肾病（CKD）、多囊肾病、囊性纤维化和先天性心脏病等慢性疾病病例的不断增加，引发了器官移植手术的数量。这些手术通常需要数小时，并且在手术过程中会流失大量血液，这导致需要输血。公私伙伴关系与移植协调员合作，为改善需要持续输血的器官移植做出了重大贡献。无论是发展中国家还是发达国家，器官移植手术的数量都在激增。作为医疗旅游目的地而备受关注的发展中国家的医疗保健行业正在不断进步，这使得它们能够提供更好、更现代的医疗服务。器官移植需求的不断增长是推动北美地区输血诊断需求的关键因素。
市场概览 ;
北美输血诊断市场已细分为美国、加拿大和墨西哥；美国是该地区市场的最大贡献者。北美输血诊断市场的增长归因于慢性疾病手术数量的增加。根据美国国家红十字组织的数据，到 2022 年，红细胞数量约为 29,000 个单位；约 5,000 单位血小板；美国每天需要约 6,500 单位的血浆。美国每年约有 1600 万份血液成分被输注。车祸受害者可能需要多达 100 个单位的血液。根据美国骨科医师学会 2018 年发布的数据，骨科手术是世界上最常见的手术之一。美国骨科医师学会进行的研究估计，到 2030 年，全关节置换术 (TJR) 手术数量可能会激增 171%，而全膝关节置换手术数量预计将激增 189%，分别达到约 635,000 例和 1.28 例分别为 100 万。因此，随着接受骨科手术的患者数量不断增加，输血的需求也在不断增加，从而带动了北美输血诊断市场的发展。
< strong> 北美输血诊断市场细分
北方美国输血诊断市场根据产品、应用、最终用户和国家进行细分。
根据应用，北美输血诊断市场分为血型和疾病筛查。到2022年，疾病筛查领域将占据更大的市场份额。就最终用户而言，北美输血诊断市场分为医院、诊断实验室、血库和血浆分馏公司。到2022年，血库领域将主导市场。北美输血诊断市场按国家划分为美国、加拿大和墨西哥； 2022 年，美国将主导市场。
雅培； BAG 诊断有限公司； Bio-Rad 实验室公司； DiaSorin SpA； F.霍夫曼-拉罗氏有限公司；南澳州格里福斯； Immucor 有限公司； Ortho 临床诊断（QuidelOrtho 公司）；商数有限；和 Thermo Fisher Scientific Inc. 是北美输血诊断市场的领先公司。
Strategic insights for North America Blood Transfusion Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,815.82 Million |
| Market Size by 2028 | US$ 2,742.80 Million |
| Global CAGR (2022 - 2028) | 7.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Blood Transfusion Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Blood Transfusion Diagnostics Market is valued at US$ 1,815.82 Million in 2022, it is projected to reach US$ 2,742.80 Million by 2028.
As per our report North America Blood Transfusion Diagnostics Market, the market size is valued at US$ 1,815.82 Million in 2022, projecting it to reach US$ 2,742.80 Million by 2028. This translates to a CAGR of approximately 7.1% during the forecast period.
The North America Blood Transfusion Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Blood Transfusion Diagnostics Market report:
The North America Blood Transfusion Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Blood Transfusion Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Blood Transfusion Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Blood Transfusion Diagnostics Market
